The PE Ratio as of December 2024 (TTM) for Nxera Pharma Co., Ltd. (SOLTF) is -23.68

According to Nxera Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -23.68. This represents a change of -42.79% compared to the average of -41.39 of the last 4 quarters.

Nxera Pharma Co., Ltd. (SOLTF) Historical PE Ratio (quarterly & annually)

How has SOLTF PE Ratio performed in the past?

The mean historical PE Ratio of Nxera Pharma Co., Ltd. over the last ten years is 67.16. The current -23.68 PE Ratio has changed -3625.94% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's PE Ratio was at its highest in in the December 2016 quarter at 2.71K. The PE Ratio was at its lowest in in the December 2019 quarter at -1436.15.

Nxera Pharma Co., Ltd. (SOLTF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Nxera Pharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nxera Pharma Co., Ltd. (SOLTF) Average PE Ratio

How has SOLTF PE Ratio performed in the past?

The current PE Ratio of Nxera Pharma Co., Ltd. (SOLTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nxera Pharma Co., Ltd. (SOLTF) PE Ratio vs. Peers

How is SOLTF’s PE Ratio compared to its peers?

Nxera Pharma Co., Ltd.’s PE Ratio is less than Gain Therapeutics, Inc. (-2.00), less than BioVie Inc. (-0.53), less than IN8bio, Inc. (-0.36), less than NewAmsterdam Pharma Company N.V. (-13.46), less than Cue Biopharma, Inc. (-1.21), less than uniQure N.V. (-3.59), less than Rocket Pharmaceuticals, Inc. (-4.22), less than Rhythm Pharmaceuticals, Inc. (-13.27), less than Solid Biosciences Inc. (-1.72), less than MeiraGTx Holdings plc (-4.90), less than Apellis Pharmaceuticals, Inc. (-16.34), greater than Blueprint Medicines Corporation (-44.93), greater than Karuna Therapeutics, Inc. (-37.08), less than Mirati Therapeutics, Inc. (-11.26), less than Day One Biopharmaceuticals, Inc. (-14.70), less than VectivBio Holding AG (-7.94), less than AVROBIO, Inc. (2.07), less than Zura Bio Limited (-5.15), less than Elevation Oncology, Inc. (-0.85), less than Hepion Pharmaceuticals, Inc. (-0.15),

Build a custom stock screener for Nxera Pharma Co., Ltd. (SOLTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nxera Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nxera Pharma Co., Ltd. (SOLTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nxera Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.